CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 期刊论文
AUTOPHAGY, 2021, 卷号: 17
作者:  Klionsky, Daniel J.;  Abdel-Aziz, Amal Kamal;  Abdelfatah, Sara;  Abdellatif, Mahmoud;  Abdoli, Asghar
收藏  |  浏览/下载：267/0  |  提交时间：2021/05/31
Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome Insights from the LUNG SAFE Study 期刊论文
ANESTHESIOLOGY, 2019, 卷号: 130, 期号: 2
作者:  Tai Pham;  Neto, Ary Serpa;  Pelosi, Paolo;  Laffey, John Gerard;  De Haro, Candelaria
收藏  |  浏览/下载：117/0  |  提交时间：2019/12/04
IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Miles, David;  Andre, Fabrice;  Gligorov, Joseph;  Verma, Sunil;  Xu, Binghe
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Miles, David;  Andre, Fabrice;  Gligorov, Joseph;  Verma, Sunil;  Xu, Binghe
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文
作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial 期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 7
作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Mano, Max S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 期刊论文
2015, 卷号: 350, 期号: 6263, 页码: 972-978
作者:  Vacchelli, Erika;  Ma, Yuting;  Baracco, Elisa E.;  Sistigu, Antonella;  Enot, David P.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial 期刊论文
2014, 卷号: 15, 期号: 6, 页码: 580-591
作者:  Andre, Fabrice;  O'Regan, Ruth;  Ozguroglu, Mustafa;  Toi, Masakazu;  Xu, Binghe
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13
Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  O'Regan, Ruth;  Ozguroglu, Mustafa;  Andre, Fabrice;  Toi, Masakazu;  Jerusalem, Guy Heinrich Maria
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13
Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). 期刊论文
2013, 卷号: 31, 期号: 15
作者:  O'Regan, Ruth;  Ozguroglu, Mustafa;  Andre, Fabrice;  Toi, Masakazu;  Jerusalem, Guy Heinrich Maria
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace